7909862

Source:http://linkedlifedata.com/resource/pubmed/id/7909862

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006826, umls-concept:C0021083, umls-concept:C0242596, umls-concept:C1521840
pubmed:issue	8907
pubmed:dateCreated	1994-6-7
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/7909862-7909866
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985213R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0140-6736
pubmed:author	pubmed-author:NossalG JGJ
pubmed:issnType	Print
pubmed:day	14
pubmed:volume	343
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1172-4
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:7909862-Antibodies, Monoclonal, pubmed-meshheading:7909862-Chemotherapy, Adjuvant, pubmed-meshheading:7909862-Colorectal Neoplasms, pubmed-meshheading:7909862-Humans
pubmed:year	1994
pubmed:articleTitle	Minimal residual disease as the target for immunotherapy of cancer.
pubmed:affiliation	Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
pubmed:publicationType	Journal Article, Comment